Jocelyn T Kim

7PUBLICATIONS
24CO-AUTHORS
Micro- and nanosystemsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2026
NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition.

Yuan Shi, Izra Abbaali, William Harvey

|Feb 14, 2025
Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

Tian-Hao Zhang, Yuan Shi, Natalia L Komarova

|Jan 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV.

Zachary O Gentry, Owen D McAteer, Jennifer L Hamad

|Jan 11, 2022
Latency reversal plus natural killer cells diminish HIV reservoir in vivo.

Jocelyn T Kim, Tian-Hao Zhang, Camille Carmona

|Jan 03, 2018
Dendritic cells efficiently transmit HIV to T Cells in a tenofovir and raltegravir insensitive manner.

Jocelyn T Kim, Emery Chang, Alex Sigal

|Jul 23, 2017
Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation.

Jocelyn T Kim, Yarong Liu, Rajan P Kulkarni

Pageof 2

Frequent Collaborators

5 joint publications

Jerome A Zack

4 joint publications

Christopher Seet

3 joint publications

Melanie Dimapasoc

2 joint publications

David Baltimore